PILA PHARMA AB (5KC) Stock Statistics & Valuation Metrics

PILA PHARMA AB has a market cap or net worth of €7.93M. The enterprise value is €136.81M.

PILA PHARMA AB has 27,126,623 shares outstanding. The number of shares has decreased by -2.65% in one year.

PILA PHARMA AB’s return on equity (ROE) is -2.14 and return on invested capital (ROIC) is -154.13%.

The current PE Ratio of PILA PHARMA AB is -8.49. PILA PHARMA AB’s PEG ratio is -0.03.

In the last 12 months, PILA PHARMA AB had revenue of 775.00K and earned -11.24M in profits. Earnings per share was -0.47.

In the last 12 months, operating cash flow was -4.96M and capital expenditures 0.00, giving a free cash flow of -4.96M billion.

PILA PHARMA AB pays an annual dividend of ―, resulting in a dividend yield of ―

PILA PHARMA AB upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.

PILA PHARMA AB as a current ratio of 5.21, with Debt / Equity ratio of 0.00%

In the past 12 months, PILA PHARMA AB has paid 0.00 in taxes.

PILA PHARMA AB EV to EBITDA ratio is -8.96, with an EV/FCF ratio of -11.58.

PILA PHARMA AB has €2.54M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€2.54M billion.

Gross margin is -472.64%, with operating margin of -1046.32%, and net profit margin of -1450.45%.

The average price target for PILA PHARMA AB is ―, which is 11.43% higher than the current price. The consensus rating is ―